OBJECTIVES: Assess population attributable fractions (PAFs) for late postnatal transmission (LPT) of HIV-1 in a cohort of HIV-1-exposed infants. METHODS: We used data established from a risk factor analysis of LPT (negative HIV-1 results through the 4-6 week visit, but positive assays thereafter through the 12-month visit) from a perinatal clinical trial conducted in 3 sub-Saharan countries. PAFs were calculated as the proportions of excess LPTs attributed to identified risk factors. RESULTS: For the cohort of 1317 infants, 206 (15.6%) had only low maternal CD4 counts (<200 cells/mm), 332 (25.2%) had only high maternal plasma viral loads (VLs) (>50,000 copies/mL), and 81 (6.2%) had both low CD4 counts and high VLs. Their PAFs were 26.0% [95% confidence interval (CI): 12.0% to 36.0%], 37.0% (95% CI: 22.0% to 51.0%), and 16.0% (95% CI: 6.0% to 25.0%), respectively. CONCLUSIONS: Our PAF analysis illustrates the public health impact of the substantial proportion of LPTs accounted for by high-risk women with both low CD4 counts and high VLs. In light of these results, access to and use of antiretroviral therapy by high-risk HIV-1-infected pregnant women is essential. Additional strategies to reduce LPT for those not meeting criteria for antiretroviral therapy should be implemented.
OBJECTIVES: Assess population attributable fractions (PAFs) for late postnatal transmission (LPT) of HIV-1 in a cohort of HIV-1-exposed infants. METHODS: We used data established from a risk factor analysis of LPT (negative HIV-1 results through the 4-6 week visit, but positive assays thereafter through the 12-month visit) from a perinatal clinical trial conducted in 3 sub-Saharan countries. PAFs were calculated as the proportions of excess LPTs attributed to identified risk factors. RESULTS: For the cohort of 1317 infants, 206 (15.6%) had only low maternal CD4 counts (<200 cells/mm), 332 (25.2%) had only high maternal plasma viral loads (VLs) (>50,000 copies/mL), and 81 (6.2%) had both low CD4 counts and high VLs. Their PAFs were 26.0% [95% confidence interval (CI): 12.0% to 36.0%], 37.0% (95% CI: 22.0% to 51.0%), and 16.0% (95% CI: 6.0% to 25.0%), respectively. CONCLUSIONS: Our PAF analysis illustrates the public health impact of the substantial proportion of LPTs accounted for by high-risk women with both low CD4 counts and high VLs. In light of these results, access to and use of antiretroviral therapy by high-risk HIV-1-infected pregnant women is essential. Additional strategies to reduce LPT for those not meeting criteria for antiretroviral therapy should be implemented.
Authors: Taha E Taha; Elizabeth R Brown; Irving F Hoffman; Wafaie Fawzi; Jennifer S Read; Moses Sinkala; Francis E A Martinson; George Kafulafula; Gernard Msamanga; Lynda Emel; Samuel Adeniyi-Jones; Robert Goldenberg Journal: AIDS Date: 2006-06-12 Impact factor: 4.177
Authors: T E Taha; N I Kumwenda; D R Hoover; R J Biggar; R L Broadhead; S Cassol; L van der Hoven; D Markakis; G N Liomba; J D Chiphangwi; P G Miotti Journal: AIDS Date: 2000-03-10 Impact factor: 4.177
Authors: J E Embree; S Njenga; P Datta; N J Nagelkerke; J O Ndinya-Achola; Z Mohammed; S Ramdahin; J J Bwayo; F A Plummer Journal: AIDS Date: 2000-11-10 Impact factor: 4.177
Authors: Barbra A Richardson; Grace C John-Stewart; James P Hughes; Ruth Nduati; Dorothy Mbori-Ngacha; Julie Overbaugh; Joan K Kreiss Journal: J Infect Dis Date: 2003-02-12 Impact factor: 5.226
Authors: Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Tom Lutalo; Fred Nalugoda; Nelson Sewankambo; Mohamed Kiduggavu; Maria Wawer; Ronald Gray Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: Charles Chasela; Ying Qing Chen; Susan Fiscus; Irving Hoffman; Alicia Young; Megan Valentine; Lynda Emel; Taha E Taha; Robert L Goldenberg; Jennifer S Read Journal: Pediatr Infect Dis J Date: 2008-03 Impact factor: 2.129
Authors: Anna Coutsoudis; Francois Dabis; Wafaie Fawzi; Philippe Gaillard; Geert Haverkamp; D Robert Harris; J Brooks Jackson; Valerie Leroy; Nicolas Meda; Philippe Msellati; Marie-Louise Newell; Ruth Nsuati; Jennifer S Read; Stefan Wiktor Journal: J Infect Dis Date: 2004-05-26 Impact factor: 5.226
Authors: Taha E Taha; Donald R Hoover; Newton I Kumwenda; Susan A Fiscus; George Kafulafula; Chiwawa Nkhoma; Shu Chen; Estelle Piwowar; Robin L Broadhead; J Brooks Jackson; Paolo G Miotti Journal: J Infect Dis Date: 2007-05-24 Impact factor: 5.226
Authors: Valériane Leroy; John M Karon; Ahmadou Alioum; Ehounou R Ekpini; Philippe van de Perre; Alan E Greenberg; Philippe Msellati; Michael Hudgens; François Dabis; Stefan Z Wiktor Journal: AIDS Date: 2003-07-04 Impact factor: 4.177